Phenex Pharmaceuticals AG:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Phenex Pharmaceuticals AG - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C7552
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Phenex Pharmaceuticals AG (Phenex Pharmaceuticals) is a drug discovery and development company that offers nuclear receptors for the development of novel therapies. The company offer services such as NR selectivity screening, contract screening services, and SNuRM profiling to pharmaceutical, veterinary medicine, biotechnology, and food companies. It carries out research and development programs in the areas of liver and gastrointestinal diseases, chronic inflammatory diseases, dermatology, diabetes, and cancer. The company also discovers and develops NR resource assays for nuclear receptors in other formats. It has its operations in Ludwigshafen and Heidelberg, Germany. Phenex Pharmaceuticals is headquartered in Ludwigshafen, Germany.

Phenex Pharmaceuticals AG – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Phenex Pharmaceuticals AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Phenex Pharmaceuticals AG, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Phenex Pharmaceuticals AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Phenex Pharmaceuticals AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Phenex Pharmaceuticals AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Phenex Pharmaceuticals AG, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Phenex Pharma Raises US$6.5 Million In Series D Financing 10
Licensing Agreements 11
Phenex Pharma Enters Into Licensing Agreement With Janssen Biotech For Retinoid-Acid Receptor-Related Orphan Receptor Gamma t Program 11
Asset Transactions 12
Gilead Sciences Acquires Farnesoid X Receptor Program from Phenex Pharma 12
Phenex Pharmaceuticals AG – Key Competitors 14
Phenex Pharmaceuticals AG – Key Employees 15
Phenex Pharmaceuticals AG – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Phenex Pharmaceuticals AG, Pharmaceuticals & Healthcare, Key Facts 2
Phenex Pharmaceuticals AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Phenex Pharmaceuticals AG, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Phenex Pharmaceuticals AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Phenex Pharmaceuticals AG, Deals By Therapy Area, 2012 to YTD 2018 8
Phenex Pharmaceuticals AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Phenex Pharma Raises US$6.5 Million In Series D Financing 10
Phenex Pharma Enters Into Licensing Agreement With Janssen Biotech For Retinoid-Acid Receptor-Related Orphan Receptor Gamma t Program 11
Gilead Sciences Acquires Farnesoid X Receptor Program from Phenex Pharma 12
Phenex Pharmaceuticals AG, Key Competitors 14
Phenex Pharmaceuticals AG, Key Employees 15
Phenex Pharmaceuticals AG, Other Locations 16

List of Figures
Phenex Pharmaceuticals AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Phenex Pharmaceuticals AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Phenex Pharmaceuticals AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Phenex Pharmaceuticals AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Phenex Pharmaceuticals AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Phenex Pharmaceuticals AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Phenex Pharmaceuticals AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Phenex Pharmaceuticals AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Phenex Pharmaceuticals AG:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Arise AB (ARISE):企業の財務・戦略的SWOT分析
    Arise AB (ARISE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Genesis Energy, L.P.:企業の戦略・SWOT・財務情報
    Genesis Energy, L.P. - Strategy, SWOT and Corporate Finance Report Summary Genesis Energy, L.P. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Sandvine Corporation:企業の戦略的SWOT分析
    Sandvine Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Kilitch Drugs India Ltd (KILITCH):製薬・医療:M&Aディール及び事業提携情報
    Summary Kilitch Drugs India Ltd (Kilitch) is a pharmaceutical company that manufactures and markets antibacterial parenteral formulations and other pharmaceutical products. The company offers products such as parenterals and nasal products, oral, effervesscent, nutritional products, medical device, …
  • Nova Kreditna banka Maribor d. d.:企業の戦略・SWOT・財務分析
    Nova Kreditna banka Maribor d. d. - Strategy, SWOT and Corporate Finance Report Summary Nova Kreditna banka Maribor d. d. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • WEG SA:戦略・SWOT・企業財務分析
    WEG SA - Strategy, SWOT and Corporate Finance Report Summary WEG SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, prov …
  • Nuance Communications Inc (NUAN):医療機器:M&Aディール及び事業提携情報
    Summary Nuance Communications Inc (Nuance) is a provider of speech and imaging solutions. The company, offers solutions such as optical character recognition (OCR), automated speech recognition, capabilities for natural language understanding, domain knowledge and implementation capabilities, dialog …
  • Och-Ziff Capital Management Group LLC (OZM):企業の財務・戦略的SWOT分析
    Summary Och-Ziff Capital Management Group LLC (Oz Management) is an alternative asset management firm that provides asset management services. The firm’s services portfolio includes portfolio management, private investments, funds management, and equity funds investment and management services. Its …
  • Gland Pharma Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Gland Pharma Ltd (Gland Pharma) is a healthcare products provider that develops and manufactures active pharmaceutical ingredients. The company’s products include injectables, pre filled syringes, vials, ampoules, infusions, ophthalmic solutions, lyophilized vials, dry powders, lyophilized p …
  • Commercial Bank Of Kuwait Sak
    Commercial Bank Of Kuwait Sak - Strategy, SWOT and Corporate Finance Report Summary Commercial Bank Of Kuwait Sak - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Inform Diagnostics Inc:医療機器:M&Aディール及び事業提携情報
    Summary Inform Diagnostics Inc(Inform Diagnostics) formerly known as Miraca Life Sciences, a subsidiary of Miraca Holdings Inc, is an anatomic pathology laboratory that offers diagnostic services. The laboratory provides services in the areas of breast health, dermatology, gastroenterology, hematolo …
  • Kracie Holdings, Ltd.:企業の戦略・SWOT・財務情報
    Kracie Holdings, Ltd. - Strategy, SWOT and Corporate Finance Report Summary Kracie Holdings, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Teikoku Seiyaku Co Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Teikoku Seiyaku Co Ltd (Teikoku Seiyaku) is a medical device company that develops, manufactures and distributes medicated and medically related supplies. The company offers Chinese medicine, other medicinal products, quasi-drugs, cosmetics, hot sensation plaster, transdermal indomethacin me …
  • Douglas GmbH:企業の戦略・SWOT・財務情報
    Douglas GmbH - Strategy, SWOT and Corporate Finance Report Summary Douglas GmbH - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Biosilu Healthcare AG (1YA)-製薬・医療分野:企業M&A・提携分析
    Summary Biosilu Healthcare AG (Biosilu Healthcare), formerly Amp Biosimilars AG is a life science company that develops and commercializes biopharmaceuticals. The company's product pipeline comprises biosimilar development projects on immune disorders and cancer. It offers products in therapeutic ar …
  • Taiwan Semiconductor Manufacturing Company Limited:企業の戦略・SWOT・財務情報
    Taiwan Semiconductor Manufacturing Company Limited - Strategy, SWOT and Corporate Finance Report Summary Taiwan Semiconductor Manufacturing Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's struct …
  • Sv. Sv. Konstantin I Elena Holding Ad
    Sv. Sv. Konstantin I Elena Holding Ad - Strategy, SWOT and Corporate Finance Report Summary Sv. Sv. Konstantin I Elena Holding Ad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Edge Therapeutics Inc (EDGE):製薬・医療:M&Aディール及び事業提携情報
    Summary Edge Therapeutics Inc (Edge Therapeutics) is a clinical-stage biotechnology company that discovers, develops and commercializes hospital-based therapies. The company offers hospital based therapies capable of transforming treatment paradigms in the management of life-threatening, acute neuro …
  • Living Proof Inc-製薬・医療分野:企業M&A・提携分析
    Summary Living Proof Inc (Living Proof) is a healthcare products provider that offers hair care products. The company offers hair travel kits, dry shampoos, hair conditioner, styling treatment kits, night cap overnight perfector, pre shampoo treatment, timeless shampoo, plumping mousse, nourishing s …
  • Saniona AB (SANION):企業の財務・戦略的SWOT分析
    Summary Saniona AB (Saniona), formerly Aniona is a research and development company that develops drugs for central nervous system diseases, autoimmune diseases, metabolic diseases and pain management. The company’s pipeline products include tesofensine, a triple monoamine reuptake inhibitor, which …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆